Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
05/09/2023
/
Publications
/
Clinical Trial
Published by the Loma Linda group, this study reported the results of their randomized trial compared PBT with TACE for HCC. Patients were randomized to receive...
Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer: A Meta-Analysis.
05/09/2023
/
Publications
Published in JAMA Network, this meta-analysis showed that photon therapy was associated with poor OS, but no...
Proton radiotherapy as a treatment strategy to increase survival in locally advanced pancreatic cancer in the body and tail: a retrospective study.
05/09/2023
/
Publications
This study from Japan reported clinical outcomes of 200 patients with locally advanced pancreatic cancer (LAPC) treated with PT to a total dose of 67.5 GyE in...
Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review.
05/09/2023
/
Publications
This review included 31 primary studies including CFRT 15, SBRT 10 and PBT 6 for evaluation. The range of median total dose reported in the CFRT group was 50.4...
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.
05/09/2023
/
Publications
This study reported results of 25 patients with localized nonresectable pancreatic cancer (15 patients) or local recurrent disease (10 patients) treated with...
Managing motion in PT
20/11/2020
/
Webinar
/
Model-based approach
Motion Management
IBA invites you to attend a webinar presented by two experts in the field of Motion Magement in Proton Therapy, Dr. Korevaar from the University Medical Centre...
Feasibility Trial of Intensity Modulated Proton Therapy to Reduce Toxicity in Anal Cancer Patients.
05/09/2023
/
Publications
This study reported toxicity of 14 patients with anal cancer treated with chemoradiation using IMPT. Rates of physician-reported GI, GU, dermatologic, and...
Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
05/09/2023
/
Publications
This study by the Heidelberg group reported clinical outcomes of 25 patients with uterine cervical or endometrial cancer treated with postoperative PBT. Proton...
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research.
05/09/2023
/
Publications
This is a model estimation for patient capacity of The Australian Bragg Centre for Proton Therapy and Research (ABCPTR), which is the first proton facility in...
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
05/09/2023
/
Publications
Published in the Green Journal, this report aimed to establish treatment indications and potential patient numbers for carbon ion radiation therapy (CIRT) at...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.